Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ALPPL2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA522336
Description
Recommended positive controls: A549. Predicted reactivity: Human (98%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The product of this gene is a membrane bound glycosylated enzyme, localized to testis, thymus.
Specifications
ALPPL2 | |
Polyclonal | |
Unconjugated | |
ALPG | |
Akp5; alkaline phosphatase 5; Alkaline phosphatase Nagao isozyme; Alkaline phosphatase, germ cell type; alkaline phosphatase, placental like 2; alkaline phosphatase, placental-like; alkaline phosphatase, placental-like 2; ALP-1; Alpg; ALPPL; ALPPL2; C77216; D1Ertd816e; EAP; Embryonic alkaline phosphatase; embryonic-type alkaline phosphatase; GCAP; Germ cell alkaline phosphatase; Nagao isozyme; Placental alkaline phosphatase-like; placental-like alkaline phosphatase; PLAP-like; RGD1565100; testicular and thymus alkaline phosphatase | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
251 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunomicroscopy, Western Blot, Immunocytochemistry | |
1 mg/mL | |
0.1M glycine, 0.1M tris with 20% glycerol and 0.01% thimerosal; pH 7 | |
P10696 | |
ALPG, ALPPL2 | |
Recombinant protein encompassing a sequence within the center region of human ALPPL2. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction